Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Neurobiome AB
AB
Active
Org 5594672262
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2024
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 0
EBITDA margin
—
Equity ratio
20.7%
Financial strength
Net profit 2024
SEK -18K
0 employees
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2024
Key figures
Annual report 2024
Revenue
SEK 0
—
EBITDA
SEK -18K
—
Net profit
SEK -18K
—
Total assets
SEK 32K
—
Equity
SEK 7K
—
Employees
0
—
Company information
Legal name
Neurobiome AB
Org number
5594672262
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9 januari 2024
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Förvaltning av vinst från aktier samt konsultverksamhet inom nutritions- och mikrobiota-forskning.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Lund
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2024
Income statement
SEK thousands
Item
2024
Revenue
0
Staff expenses
—
EBITDA
−18
Depreciation & amort.
—
EBIT
−18
Net financials
—
Profit before tax
−18
Tax
—
Net profit
−18
Balance sheet
SEK thousands
Item
2024
Total assets
32
Equity
7
Long-term debt
—
Short-term debt
25
Total debt
25
Financial ratios
5-year trend
EBITDA margin
-1846200.0%
This company
15.8%
Market median
-11684910% vs market
2024
2024
Equity ratio
20.7%
This company
38.2%
Market median
-46% vs market
2024
2024
Return on equity
-282.4%
This company
18.4%
Market median
-1635% vs market
2024
2024
Net profit margin
-1846200.0%
This company
8.1%
Market median
-22792693% vs market
2024
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2024
2024
Debt / equity
3.82×
This company
0.62×
Market median
-516% vs market
2024
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-09 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
FJ
Frida Johanna Hållenius
Chief Executive Officer
Chief Executive Officer
2024
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
LS
Lars-Gunnar Svensson
Deputy Board Member
2024
Former (2)
CA
Christoffer Axel Linnér
Deputy Board Member
2024 – 2024
JO
Johan Oskar David Cimmerholm
Board of Directors
2024 – 2024
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Neurobiome AB also hold positions in
0
other companies.
Person
Role here
Other companies
Frida Johanna Hållenius
Chief Executive Officer
0 companies
Lars-Gunnar Svensson
Deputy Board Member
0 companies
Christoffer Axel Linnér
Deputy Board Member
0 companies
Johan Oskar David Cimmerholm
Board of Directors
0 companies